(Q40751031)

23 September 2017

title

A novel series of hybrid compounds derived by combining 2-aminotetralin and piperazine fragments: binding activity at D2 and D3 receptors (English)

1 reference

23 September 2017

Aloke K Dutta

1

1 reference

23 September 2017

Xiang-Shu Fei

series ordinal

2

1 reference

23 September 2017

Maarten E A Reith

series ordinal

3

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Bioorganic & Medicinal Chemistry Letters

23 September 2017

published in

1 reference

23 September 2017

volume

12

1 reference

23 September 2017

issue

4

1 reference

23 September 2017

page(s)

619-622

1 reference

Molecular diversity of the dopamine receptors

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

Multiple receptors for dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

D3 dopamine receptor mRNA is widely expressed in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

Dopamine D3 receptor: basic and clinical aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

Modulation of cocaine self-administration in the rat through D-3 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

Cerebral dopamine agonist properties of some 2-aminotetralin derivatives after peripheral and intracerebral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

Synthesis and pharmacology of some 2-aminotetralins. Dopamine receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

Lack of discrimination by agonists for D2 and D3 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

Phenylpiperazine derivatives with strong affinity for 5HT1A, D2A and D3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

2-aminotetralin-derived substituted benzamides with mixed dopamine D2, D3, and serotonin 5-HT1A receptor binding properties: a novel class of potential atypical antipsychotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

NGB 2904 and NGB 2849: two highly selective dopamine D3 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900820-4

7 January 2021

10.1016/S0960-894X(01)00820-4

Identifiers

DOI

1 reference

23 September 2017

1 reference